Targeting the ATR-CHK1 Axis in Cancer Therapy

By Rundle Stuart   Bradbury Alice   Drew Yvette   Curtin Nicola J.  

Cancers, Vol. 9, Iss. 5, 2017-04 ,pp. : 41-41

MDPI

Access to resources Recommend Favorite

Chk1 knockdown confers radiosensitization in prostate cancer stem cells

By Wang Xiaobin   Ma Zhikun   Xiao Zheng   Liu Hui   Dou Zhongling   Feng Xiaoshan   Shi Haijun  

Oncology Reports, Vol. 28, Iss. 6, 2012-12 ,pp. : 2247-2254

Spandidos Publications

Access to resources Recommend Favorite

Screening for large genomic rearrangements of the BRIP1 and CHK1 genes in Finnish breast cancer families

By Solyom Szilvia  

Familial Cancer, Vol. 9, Iss. 4, 2010-12 ,pp. : 537-540

Springer Publishing Company

Access to resources Recommend Favorite

ACE Inhibitors: A Novel Treatment for Neurofibroma

By Namazi Hamid  

Annals of Surgical Oncology, Vol. 15, Iss. 5, 2008-05 ,pp. : 1538-1539

Springer Publishing Company

Access to resources Recommend Favorite

The Chk1 inhibitor AZD7762 sensitises p53 mutant breast cancer cells to radiation in vitro and in vivo

By            

Molecular Medicine Reports, Vol. 6, Iss. 4, 2012-01 ,pp. : 897-903

Spandidos Publications

Access to resources Recommend Favorite